CLDX - CIK 0000744218
Celldex Therapeutics, Inc. (CLDX) reported net income of -$258.76M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$258.76M | -63.9% |
| FY 2024 | -$157.86M | -11.6% |
| FY 2023 | -$141.43M | -25.9% |
| FY 2022 | -$112.33M | -59.3% |
| FY 2021 | -$70.51M | - |
Celldex Therapeutics, Inc. (CLDX) reported net income of -$258.76M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2021 and fiscal 2025, Celldex Therapeutics, Inc.'s net income declined from -$70.51M to -$258.76M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.